A federal jury in California dominated Friday that Apple should pay medical machine maker Masimo $634 million for infringing a patent on blood oxygen monitoring expertise.
Reuters studies the jury discovered that the Apple Watch’s exercise mode and coronary heart fee notification options violated Masimo’s patent.
“It is a important win in our ongoing efforts to guard our improvements and mental property, which is essential to our skill to develop expertise that advantages sufferers,” Masimo mentioned in an announcement. “We stay dedicated to defending our IP rights shifting ahead.”
An Apple spokesperson advised Reuters that the corporate plans to attraction the decision, including, “The one patent on this case expired in 2022, and is particular to historic affected person monitoring expertise from a long time in the past.”
TechCrunch has reached out to Apple for added remark.
The authorized dispute between Masimo and Apple focuses on pulse oximetry, which makes use of an optical sensor to detect blood circulation. Masimo has accused Apple of hiring away its staff — together with its chief medical officer — and infringing its patents on pulse oximetry expertise.
The U.S. Worldwide Commerce Fee sided by Masimo in 2023, banning Apple from importing Apple Watches with blood oxygen monitoring options — which is why Apple Watches haven’t supported blood oxygen monitoring lately.
Techcrunch occasion
San Francisco
|
October 13-15, 2026
Then Apple introduced in August of this 12 months that it’s introducing a brand new model of the characteristic designed to avoid the ban, with blood oxygen readings measured and calculated on the person’s paired iPhone, relatively than the Apple Watch itself.
Masimo is suing U.S. Customs and Border Patrol for approving the import of Apple Watches with the brand new blood oxygen implementation, whereas Apple has requested an appeals courtroom to overturn the import ban.
Apple additionally countersued Masimo, successful the statutory minimal fee of $250 when a jury discovered that Masimo had violated Apple design patents.
